Sorrento Therapeutics Inc.

09/26/2022 | Press release | Distributed by Public on 09/26/2022 07:06

Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK)[...]